Near-Infrared Light and Photobiomodulation

Definitions

Photobiomodulation (PBM) was previously known as low-level laser light therapy. It is a noninvasive phototherapy using red and near-infrared light. [1] Near-infrared (NIR) covers about 700 to 1440 nm in one dermatology review, beyond visible red. [1] Red-light basics are in red-light therapy: what research shows. This page does not give treatment settings. Evidence labels used: established, promising but limited, mixed, insufficient evidence, preclinical (cells/animals only), no good evidence of benefit and Proper evidence not found (we looked and found nothing usable).

Clinical use versus wellness use

In medicine, PBM is used under professional direction for a defined condition, with specified device parameters. Wellness use is self-directed, for broad goals (recovery, energy, longevity), usually with consumer panels or wraps. Evidence for the first does not carry to the second. The US FDA draft guidance for PBM devices covers class II medical devices and says low-risk, general-wellness-only light products may be outside its scope. [2]

What research shows

1. Preventing oral mucositis in specific cancer treatments

   established (prevention, defined settings)

   International supportive-care guideline recommends PBM for prevention in defined settings; no guideline possible for established sores or chemotherapy-related sores [3]

2. Knee osteoarthritis pain

   promising but limited

   Meta-analysis of 22 placebo-controlled trials (1,063 participants): pain reduced versus placebo; no adverse events reported [4]

3. Hair loss

   promising but limited

   36 studies (966 patients), infrared and red light effective for androgenetic alopecia, mixed study designs [5]

4. Acne

   no good evidence of benefit

   Cochrane review: infrared light versus no treatment showed no clinically significant effects [6]

5. Brain, sleep, longevity, general recovery

   marketing claim if promoted

   Proper evidence not found in the reviews we read

The knee analysis notes that low-level laser therapy is not recommended in major knee osteoarthritis treatment guidelines, and that the question it tested was whether a dose-response relationship exists. [4] That analysis concerns low-level laser therapy at specific wavelengths; it did not show that consumer LED panels give the same result.

Why the evidence is hard to compare

A systematic review of 74 PBM papers found 73% did not report how light was measured, and key parameters such as irradiance (43%) and beam area (40%) were often missing; incorrect terminology was frequent. [7] Another review counted more than three dozen parameters proposed for describing laser dose, and said missing or inaccurate reporting makes studies hard to compare. [8] A dermatology review says effective PBM depends on treatment parameters such as fluence, duration and output power. [1] A mechanisms review notes PBM can have apparently opposite effects in healthy versus stressed cells. [9] So "more power" or "longer" is not a safe rule, and we publish no protocols.

Mechanism claims

Researchers suggest light is absorbed by mitochondrial cytochrome c oxidase, altering energy production, reactive oxygen species and calcium. [1] Label: preclinical as a basis for human benefit. Cell findings do not establish effects on a person's organs.

How to evaluate claims

• Match the wavelength, device and body area in the claim to the study cited.
• Look for measured irradiance, not just "watts" or LED counts: light device specifications.
• Ask whether the result is pain relief in trials or a lab marker change. Biomarker change is not a clinical outcome.